135 related articles for article (PubMed ID: 7631264)
1. Efficacy of prophylactic application of immunoglobulins in radiation induced mucositis.
Mose S; Adamietz IA; Saran F; Thilmann C; Heyd R; Böttcher HD
Strahlenther Onkol; 1995 Jul; 171(7):415-6. PubMed ID: 7631264
[No Abstract] [Full Text] [Related]
2. Can prophylactic application of immunoglobulin decrease radiotherapy-induced oral mucositis?
Mose S; Adamietz IA; Saran F; Thilmann C; Heyd R; Knecht R; Böttcher HD
Am J Clin Oncol; 1997 Aug; 20(4):407-11. PubMed ID: 9256900
[TBL] [Abstract][Full Text] [Related]
3. [Immunoglobulin for prevention of radiogenic mucositis].
Mose S; Adamietz IA; Thilmann C; Saran F; Heyd R; Knecht R; Böttcher HD
HNO; 1995 Jul; 43(7):421-6. PubMed ID: 7672999
[TBL] [Abstract][Full Text] [Related]
4. [Prevention of radiochemotherapy-induced mucositis. Value of the prophylactic mouth rinsing with PVP-iodine solution].
Adamietz IA; Rahn R; Böttcher HD; Schäfer V; Reimer K; Fleischer W
Strahlenther Onkol; 1998 Mar; 174(3):149-55. PubMed ID: 9524624
[TBL] [Abstract][Full Text] [Related]
5. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck.
Law A; Kennedy T; Pellitteri P; Wood C; Christie D; Yumen O
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1361-8. PubMed ID: 17869022
[TBL] [Abstract][Full Text] [Related]
7. [Cytoprotection with amifostine in radiotherapy or radio-chemotherapy of head and neck tumors].
Altmann S; Hoffmanns H
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():30-3. PubMed ID: 10584138
[TBL] [Abstract][Full Text] [Related]
8. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
9. [Radiation-induced mucositis and neutrophil granulocytes in oral mucosa].
Schmidberger H; Rave-Fränk M; Kim S; Hille A; Pradier O; Hess CF
Strahlenther Onkol; 2003 Oct; 179(10):667-72. PubMed ID: 14566474
[TBL] [Abstract][Full Text] [Related]
10. [Tranexamic acid in the prevention of oropharyngeal radiomucositis].
Mevio E; Santarelli P
Radiol Med; 1983 May; 69(5):325-6. PubMed ID: 6658041
[TBL] [Abstract][Full Text] [Related]
11. Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer.
Rashad UM; Al-Gezawy SM; El-Gezawy E; Azzaz AN
J Laryngol Otol; 2009 Feb; 123(2):223-8. PubMed ID: 18485252
[TBL] [Abstract][Full Text] [Related]
12. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
[TBL] [Abstract][Full Text] [Related]
13. [Can the prophylactic treatment of mycotic mucositis improve the time of performing radiotherapy in head and neck tumors?].
Gava A; Ferrarese F; Tonetto V; Coghetto F; Marazzato G; Zorat PL
Radiol Med; 1996 Apr; 91(4):452-5. PubMed ID: 8643858
[TBL] [Abstract][Full Text] [Related]
14. [Local reactions and complications (injuries) in the radiation therapy of malignant head and neck tumors. Their prevention and treatment].
Vorob'ev IuI
Med Radiol (Mosk); 1991; 36(3):50-2. PubMed ID: 2017007
[No Abstract] [Full Text] [Related]
15. Combined radiotherapy and chemotherapy with carboplatin and UFT for head and neck squamous cell carcinoma.
Taguchi T; Ikeda Y; Mikami Y; Kawai S; Arai Y; Mochimatsu I; Tsukuda M
Anticancer Res; 2003; 23(1B):713-7. PubMed ID: 12680172
[TBL] [Abstract][Full Text] [Related]
16. Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study.
Buentzel J; Micke O; Adamietz IA; Monnier A; Glatzel M; de Vries A
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):684-91. PubMed ID: 16243440
[TBL] [Abstract][Full Text] [Related]
17. [Side effects of postoperative radiochemotherapy with amifostine versus radiochemotherapy alone in head and neck tumors. Preliminary results of a prospective randomized trial].
Vacha P; Marx M; Engel A; Richter E; Feyerabend T
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():18-22. PubMed ID: 10584135
[TBL] [Abstract][Full Text] [Related]
18. [A combination of low-dose carboplatin (CBDCA) and radiation therapy in head and neck cancer patients--response and hematologenic toxicity].
Watanabe N; Kaneko T; Fujitani S; Umeyama M; Nomura Y; Zusho H; Yamada Y; Nanba G; Asahina N; Sugio Y; Okamoto Y; Daida T; Tokumaru T
Gan To Kagaku Ryoho; 1999 Jan; 26(1):101-6. PubMed ID: 9987505
[TBL] [Abstract][Full Text] [Related]
19. Povidone-iodine to prevent mucositis in patients during antineoplastic radiochemotherapy.
Rahn R; Adamietz IA; Boettcher HD; Schaefer V; Reimer K; Fleischer W
Dermatology; 1997; 195 Suppl 2():57-61. PubMed ID: 9403257
[TBL] [Abstract][Full Text] [Related]
20. Concomitant administration of two standard regimens of chemotherapy and radiotherapy in advanced squamous carcinoma of the head and neck: a feasibility study.
Benasso M; Corvò R; Numico G; Cavallari M; Blengio F; Sanguineti G; Rosso M; Merlano M
Anticancer Res; 1995; 15(6B):2651-4. PubMed ID: 8669841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]